Co-Editors @ebtapper and Carmen Chak-Lui Wong highlight October's @HepCommJournal, featuring liver decompensation, acute kidney injury in alcohol-associated hepatitis, pediatric PSC, ferroptosis, and more! Watch below and explore the issue: journals.lww.com/hepcomm/toc… youtu.be/QniIrUn-Sfo

The countdown is on! ⏳ In less than a few weeks, the hepatology community unites for 5 days of game-changing research, fresh clinical perspectives, and in-person connections that spark real progress in liver care. #TLM26 Stay tuned for updates and announcements as we gear up for kickoff. 🎉 #Hepatology #LiverCare #AASLD

The new PBC guideline is now published! Attending #TLM26? Explore key updates at two expert-led sessions: 🔹 Nov. 6: From Evidence to Practice bit.ly/4zEf62g 🔹 Nov. 7: Inside the Journals: AASLD AGA Guideline on Management of PBC bit.ly/3WFlvvU

Continue your support during #LiverCancerAwarenessMonth by getting back to the fundamentals of liver cancer. Explore this course of short video interviews covering hepatocellular carcinoma (HCC) topics. Register now at bit.ly/4g0zNyM. #embolization #radioembolization #immunotherapy #radiation

From education and new insights to conversations with colleagues and connections across the hepatology community, here’s just a glimpse of what could be on your agenda at #TLM26. What will your days at TLM look like? 👀 #Hepatology #LiverResearch

🔥 HOT TOPIC 📙 @LTxJournal How have liver transplant trends for PBC and PSC changed over the past two decades? Drawing on two major registries and more than 22,000 recipients across the U.S. and Europe, this study reveals divergent transplant trends, long-term outcomes and predictors of mortality—highlighting both advances and persistent unmet needs in cholestatic liver disease. Read the article: bit.ly/4dqn4Uc

Keep the latest liver research in your feed. 🔬 Follow the AASLD Publications Showcase on LinkedIn for monthly highlights from @HEP_Journal, @LTxJournal, and @HepCommJournal, featuring noteworthy studies, emerging insights, and research advancing liver disease care. 📲 Stay connected to the research shaping the future of hepatology: bit.ly/44Qh0jj

🏅 Turn your contributions into recognition. Your work is helping advance #hepatology. Take the next step by applying for Fellow of the AASLD (FAASLD) or Associate Fellow of the AASLD recognition. Join a distinguished community of professionals recognized for their contributions to #liverdisease research and care. 🔗 Learn more and apply by Tuesday, Dec. 15: bit.ly/3DafgH0.

The CDC’s Division of Viral Hepatitis has released its 2030 Strategic Plan, outlining priorities to prevent infections, reduce health disparities, and improve surveillance. AASLD remains committed to supporting efforts to eliminate viral hepatitis. 🔗 Learn more at the AASLD Policy Communications webpage: aasld.org/policy-communicati…

🆕 Introducing AASLD EXPOs! AASLD has published its first-ever Expert-Based Practice Opinion #EXPO. The inaugural EXPO: #LiverBiopsy, published in @HEP_Journal, delivers timely, expert-informed guidance on the evolving role of liver biopsy. 🔗 Learn more: bit.ly/4dH2I9l @elizabeth_verna @DouglasAdlerMD @LizRandLiverDoc @ebtapper

Keep your education on-the-go with our Oct. 27 webinar discussing newly proposed definitions of #obesity and the genetic and metabolic factors in the pathogenesis of lean #MASLD. Hear from the experts on this timely discussion and register today bit.ly/3W5SXeQ. #METALD #ALD

🎉 A historic milestone for AASLD journals! @HEP_Journal has achieved its highest-ever #ImpactFactor of 21.3, reinforcing its position as a global leader in liver research and scientific discovery. The milestones don't stop there! @HepCommJournal also reached a record-high Impact Factor of 6.2. These achievements reflect the exceptional contributions of our authors, reviewers, and editorial teams and AASLD's continued commitment to advancing liver science and improving patient care worldwide. Read the full announcement: bit.ly/4jndxRJ

Come for the science and stay for the community. 🫶 Nothing replaces being in the same space with people who share your passion! Who’s ready to expand their network and reconnect with the hepatology family? Drop a 💚 if we'll see you there! #TLM26 #Hepatology #HepatologyCommunity

🗳️ The results are in! Congratulations to AASLD’s newly elected leaders! Thank you to all members who participated in the 2027 General Election. Meet your newly elected leaders below. ⬇️ @jmarrero6713 @TatyanaKushner

🔥 HOT TOPIC 📘 @HepCommJournal Nearly 1 in 5 youth with biopsy-confirmed #MASLD began drinking during adolescence or early adulthood. In the largest longitudinal study of its kind, researchers followed more than 1,100 youth and found that alcohol use was associated with faster increases in liver enzymes, reinforcing the importance of routine alcohol screening and developmentally tailored counseling in pediatric MASLD care. Read the article: bit.ly/4rPDaN0

🔥 HOT TOPIC 📗 @HEP_Journal For patients with #MASLD and elevated FIB-4, which elastography method works best for the next step? A large, diverse study finds that shear wave elastography and vibration-controlled transient elastography offer similar risk stratification performance in FIB-4–based two-step algorithms, supporting flexibility in how clinicians assess risk in real-world practice. Read the article: bit.ly/4yARD1R

⏰ Deadline approaching! Secure your #TLM26 Awards & Honors Gala tickets or table sponsorship by Thursday, Oct. 15. Join us Saturday, Nov. 7, as we celebrate the achievements and contributions of the #hepatology community. 🎟️ Tickets and table sponsorships must be purchased by this Thursday, Oct. 15. bit.ly/4hhcBLK

Pair AASLD's publication resources with AASLD online courses to deepen your understanding of liver cancer and care. Course topics include #hcc, #systemictherapy for liver cancer, and #palliative care. - Just Released! Liver Cancer Systemic Therapy Certificate Program - Liver Cancer 100: The Fundamentals of Liver Cancer Care - Palliative Care and Advanced Liver Disease - HCC in the Real World: Evolving Paradigms for High-Risk Patients Read the full press release to learn more: bit.ly/4hRaOh1 #LiverCancerAwarenessMonth